CD40 and neoplasm: In addition, in a recent study, macrophage depletion using the F4/80 antibody in elderly mice improved the IL-2/anti-CD40 treatment response and achieved up to 78% tumor regression compared to 38% tumor regression in the intact macrophages control and reduced age-related treatment-induced cachexia [93].